ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645210 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645210; 2) Community: the network communities that were significantly associated with the response to NSC 645210; 3) Molecule: the relationships between components within communities and NSC 645210; 4) MDR: the compounds that were significantly associated with the NSC 645210.

NSC Compound Enrichment Correlation
NSC 710716 Null 0.0435808621943462 0.39435028
NSC 720297 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate~ -3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spiro-1"-(4"-t-butyl)cyclohexane 0.0435808621943462 0.25741622
NSC 721049 7Z-Plakortide H 0.0435808621943462 0.28703944
NSC 722781 trans-bis(acetato)amminepyridineplatinum(II) 0.0435808621943462 0.44664868
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0435808621943462 0.34445282
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0435808621943462 0.52602587
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0435808621943462 0.27289801
NSC 740 Methotrexate 0.0435808621943462 0.10206457
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.0435808621943462 0.18374931
NSC 756053 Null 0.0435808621943462 -0.1712875
Total:119  Current:116    [First] [Prev] [Next] [Last]